A new study, published in JMIR Formative Research, has found that people who answered a brief quiz to determine their "eating ...
Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander ...
Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...
The Trump administration’s recent deal with drug manufacturers to lower the cost of popular GLP-1 weight-loss medications is a "game-changer," but the price for many Americans would still be too high ...
President Donald Trump hailed his deal to slash the price of blockbuster weight loss drugs as a game changer, promising to make Wegovy and Zepbound more affordable for millions of Americans. But major ...
Regal Weight Loss Celebrates Grand Re-Opening Across DFW, Launching Updated Non-Surgical, Provider-Supervised Programs for Safe and Sustainable Results. NY, UNITED ...
Share on Pinterest A new study finds that GLP-1 drugs’ heart health benefits may not be solely due to weight loss. The Good Brigade/Getty Images As the popularity of GLP-1 receptor agonists for weight ...
Powered by 25 years of research, this program pairs patented nutrition technology with personalized medical nutrition to rebuild metabolic and heart health. LOS ANGELES, Oct. 23, 2025 /PRNewswire/ -- ...
The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...
FDA's new voucher could shorten drug review to 1-2 months Lilly's orforglipron targets high-burden chronic condition Analysts predict price erosion due to new market entrants Sept 16 (Reuters) - Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results